Effect on the Quality of Peer Review of Blinding Reviewers and Asking Them to Sign Their ReportsUniform format for disclosure of competing interests in ICMJE journalsUniform format for disclosure of competing interests in ICMJE journalsCharacterisation of trials where marketing purposes have been influential in study design: a descriptive studyAdequacy of authors' replies to criticism raised in electronic letters to the editor: cohort studyDoctors and climate changeWhat should we do about climate change? Health professionals need to act now, collectively and individuallyOpen access to peer-reviewed research: making it happen.Open letter to Roche about oseltamivir trial data.Withdraw approval for Tamiflu until NICE has full data.Open letter: European Medicines Agency should remove barriers to access clinical trial data.Making reviewers visible: openness, accountability, and credit.Effects of training on quality of peer review: randomised controlled trial.Academic boycott of Israel: follow-up to the BMJ's debateData sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors.Effect of different financial competing interest statements on readers' perceptions of clinical educational articles: study protocol for a randomised controlled trialThe BMJ is evolvingData Sharing Statements for Clinical Trials.General practitioners say that evidence based information is changing practice.Toward more uniform conflict disclosures: the Updated ICMJE conflict of interest reporting form.Dealing with editorial misconduct.An international standard for disclosure of clinical trial information.Uniform format for disclosure of competing interests in ICMJE journals.The European Medicines Agency's plans for sharing data from clinical trials.Data Sharing Statements for Clinical Trials - A Requirement of the International Committee of Medical Journal Editors.Judging the benefits and harms of medicines.The new BMJ policy on sharing data from drug and device trials.Involving patients in the BMJ.Toward more uniform conflict disclosures: updated ICMJE conflict of interest reporting form.Scientific literature's open sesame?Clinical trial registration: looking back and moving ahead.Clinical trial registration.The future of specialist trainingToward more uniform conflict disclosures--the updated ICMJE reporting form for disclosure of potential conflicts of interest.Cardiovascular risk from drugs. Editor's reply.Reed Elsevier's arms trade.Investigating allegations of scientific misconduct.Managing suspected research misconduct.Reducing the carbon footprint of medical conferences.Uniform format for disclosure of competing interests in ICMJE Journals.
P50
P98
Q24289549-45B36A10-C3C4-40BE-BFA4-B214CF3B8739Q28261312-9D1F23F6-4875-45EA-AD8C-FE230D4E7830Q28261652-B9FE2902-983B-4ACA-AB32-0B851FAC5393Q28552705-8F6880BC-0B55-4442-9DBE-EADD3EDB88B9Q28749806-32ADB68A-6619-47AC-99F6-AD53606134F6Q28756602-F99611E1-A95B-49C2-BC9C-CE455C81C254Q28766806-A1BEC644-5A87-423C-A644-B12D138074BFQ30482566-169E8B43-38E2-4F40-A5E6-701DA8328692Q30575295-12753331-A0FF-46D5-936D-24FF12E36201Q30581326-86C878BD-1DB6-4234-BD9D-DA230BE420DFQ30829565-F7D1375F-E81B-4EF8-9A6A-77A9A9199014Q34661886-5CB468BA-ACA0-4356-9807-0F796B771D09Q35680672-5ED281B7-0F3D-4EBB-8108-1A20F0294011Q35924744-0EA7C858-5614-4C07-9E3D-ADBAB6C1920AQ36396354-477AC314-C5E3-4801-ADA5-5B34526D1247Q37007075-FCF2AA8E-F59C-4CBA-A3E2-973BDAF9CE6EQ40960799-AC59CBB0-F40E-4C9C-8BC0-2A75237F0B57Q42331748-28145D4A-DEFB-487F-9F15-9BC6901ECDA2Q42414946-5C4E01A9-BB4E-4BDC-8CB3-FD94379F0476Q42434316-6FAFD5D0-C71F-44EE-8817-79760CA6186AQ42496323-D50F92D1-B333-435B-95AF-6622BE1219A2Q42584553-C4BF1925-877D-4306-8502-7B4F0FEE685EQ42587791-5A5B8A1F-2C38-41C1-9FC8-27FB09C84BFFQ42598508-761C59F1-89B4-4D0E-99DA-7915A2E62342Q42669856-0105D458-19CC-414A-8C45-B4F1C86EDDC9Q42674745-C3FAD5D5-F818-440A-8830-021D2D2CAE05Q42677549-6329B06C-E43E-4884-951F-58F201FC205FQ42722711-33055AD2-69A4-461A-84E7-2329B9141F23Q42736132-5DA1EF34-55CE-484D-8A6F-3CF84A0C760EQ42738304-ECF6AA4B-6E5D-4236-A494-0F75324DFFA3Q42741626-8CE63140-4689-4234-82FC-53F00D68D268Q42749731-54223DBF-D381-4AF5-906C-49C99C132F50Q42773451-449ADAF7-9F62-45CD-B00F-29EFFD660385Q42840766-A89E1411-AB4E-4227-9318-C320B79AACDBQ42873505-E89451B9-4687-4CB6-BADE-805E043F1C51Q42913745-D128193A-394B-4A18-ACC4-C32A69A74284Q42929281-A3568324-11BD-43C6-BF03-BCEADEAD37A3Q42947334-2D0E779D-0D3C-40BE-B669-3B4502C9C5C2Q42951682-4D7B1171-EDC5-49EC-8BBC-2825DDA3EC10Q43005411-B80644E9-3EAF-4B21-A17C-1BDAFFA246E4
P50
description
American journal editor
@en
dokter asal Britania Raya
@id
médica británica
@ast
name
Fiona Godlee
@ast
Fiona Godlee
@ca
Fiona Godlee
@de
Fiona Godlee
@en
Fiona Godlee
@es
Fiona Godlee
@fr
Fiona Godlee
@ga
Fiona Godlee
@nl
Fiona Godlee
@sl
فیونا قادلی
@azb
type
label
Fiona Godlee
@ast
Fiona Godlee
@ca
Fiona Godlee
@de
Fiona Godlee
@en
Fiona Godlee
@es
Fiona Godlee
@fr
Fiona Godlee
@ga
Fiona Godlee
@nl
Fiona Godlee
@sl
فیونا قادلی
@azb
prefLabel
Fiona Godlee
@ast
Fiona Godlee
@ca
Fiona Godlee
@de
Fiona Godlee
@en
Fiona Godlee
@es
Fiona Godlee
@fr
Fiona Godlee
@ga
Fiona Godlee
@nl
Fiona Godlee
@sl
فیونا قادلی
@azb
P1006
P214
P244
P269
P646
P1006
P101
P106
P1343
P21
P213
0000 0000 7693 8549
P214
P244
nr00003106